You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

exophthalmos

Showing 26 - 50 of 89
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Graves Ophthalmopathy Trial in São Paulo (Orbital decompression)

Completed
  • Graves Ophthalmopathy
  • Orbital decompression
  • São Paulo, Brazil
    University of Sao Paulo General Hospital
Aug 11, 2019

Bone Metastases Trial (Denosumab, Zoledronic Acid)

Completed
Has Results
  • Bone Metastases
  • Denosumab
  • Zoledronic Acid
  • (no location specified)
Nov 4, 2022

Multiple Myeloma Trial in Worldwide (Pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Graz, Austria
  • +111 more
Dec 10, 2021

Mantle Cell Lymphoma Trial in Worldwide (Bendamustine, Rituximab, Ibrutinib)

Active, not recruiting
Has Results
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +201 more
Jan 27, 2023

B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease

Terminated
  • Thyroid Eye Disease
    • Pittsburgh, Pennsylvania
      University of Pittsburgh
    Nov 14, 2019

    Prostate Cancer Trial in Worldwide (Enzalutamide, Abiraterone, Placebo for Enzalutamide)

    Completed
    Has Results
    • Prostate Cancer
    • Boston, Massachusetts
    • +91 more
    Jan 18, 2023

    Melanoma Trial in France, Germany, United States (Talimogene laherparepvec, Ipilimumab)

    Completed
    Has Results
    • Melanoma
    • Tucson, Arizona
    • +39 more
    Mar 9, 2022

    Pulmonary Arterial Hypertension Trial in Worldwide (UT-15C (treprostinil diolamine))

    Completed
    Has Results
    • Pulmonary Arterial Hypertension
    • UT-15C (treprostinil diolamine)
    • Phoenix, Arizona
    • +152 more
    May 6, 2022

    Relapsing Remitting Multiple Sclerosis Trial in Worldwide (alemtuzumab GZ402673)

    Completed
    Has Results
    • Relapsing Remitting Multiple Sclerosis
    • alemtuzumab GZ402673
    • Cullman, Alabama
    • +130 more
    Mar 21, 2022

    Myopia Trial in Fort Worth (ACRYSOF CACHET Phakic Lens (L-series))

    Completed
    Has Results
    • Myopia
    • ACRYSOF CACHET Phakic Lens (L-series)
    • Fort Worth, Texas
      Contact Alcon Call Center for Trial Locations
    Jun 25, 2019

    Relapsed DLBCL, Refractory DLBCL Trial in Worldwide (Ibrutinib, Lenalidomide, Rituximab)

    Completed
    Has Results
    • Relapsed Diffuse Large B-Cell Lymphoma
    • Refractory Diffuse Large B-Cell Lymphoma
    • Birmingham, Alabama
    • +39 more
    Jan 6, 2022

    Solid Tumor Trial in United States (PLX3397)

    Completed
    Has Results
    • Solid Tumor
    • Scottsdale, Arizona
    • +12 more
    Dec 6, 2021

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +231 more
    Jun 16, 2020

    Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD) Trial in Worldwide (Epanova®

    Completed
    Has Results
    • Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
    • Epanova® (omega-3 carboxylic acids)
    • corn oil control
    • Birmingham, Alabama
    • +684 more
    Aug 16, 2021

    Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM) Trial in Worldwide (Ranibizumab

    Completed
    Has Results
    • Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)
    • Ranibizumab 0.5mg
    • +2 more
    • Beijing, Beijing, China
    • +46 more
    Mar 31, 2019

    Multiple Myeloma Trial in Worldwide (Panobinostat, Bortezomib, Dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Phoenix, Arizona
    • +209 more
    Mar 8, 2020

    Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (AZD9150, MEDI4736, AZD5069)

    Active, not recruiting
    Has Results
    • Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck
    • Birmingham, Alabama
    • +42 more
    Oct 3, 2022

    Metastatic Breast Cancer Trial in Worldwide (fulvestrant, anastrozole)

    Completed
    Has Results
    • Metastatic Breast Cancer
    • Frederick, Maryland
    • +40 more
    Aug 14, 2019

    Triple-Negative Breast Tumors, NSCLC, Head and Neck Carcinoma, Squamous Cell Trial in Worldwide (TAK-659, Nivolumab)

    Terminated
    Has Results
    • Triple-Negative Breast Neoplasms
    • +3 more
    • La Jolla, California
    • +21 more
    Mar 18, 2020

    Heart Failure, Respiratory Insufficiency, Stroke Acute Trial in Worldwide (Rivaroxaban, 10 mg, Rivaroxaban, 7.5 mg, Placebo)

    Completed
    Has Results
    • Heart Failure
    • +4 more
    • Rivaroxaban, 10 mg
    • +2 more
    • Birmingham, Alabama
    • +616 more
    Nov 5, 2019

    T-cell Acute Lymphoblastic Leukemia, T-cell Lymphoblastic Lymphoma Trial in Worldwide (LY3039478, Dexamethasone, Placebo)

    Completed
    Has Results
    • T-cell Acute Lymphoblastic Leukemia
    • T-cell Lymphoblastic Lymphoma
    • Duarte, California
    • +21 more
    Aug 28, 2019

    Choroidal Neovascularization, Macular Edema, Glaucoma, Neovascular Trial in France (ranibizumab)

    Completed
    Has Results
    • Choroidal Neovascularization
    • +3 more
    • Bobigny cedex, Seine Saint Denis, France
    • +38 more
    Jul 2, 2019

    Solid Tumors Trial in Worldwide (Avelumab)

    Completed
    Has Results
    • Solid Tumors
    • Goodyear, Arizona
    • +73 more
    Oct 26, 2021

    Cancer, Hematologic Malignancies, Multiple Myeloma Trial in Worldwide (Denosumab, Zoledronic acid, Placebo to Denosumab)

    Completed
    Has Results
    • Cancer
    • +5 more
    • Tucson, Arizona
    • +308 more
    Mar 19, 2020

    Epilepsy, Monotherapy Trial in Worldwide (Lacosamide, Carbamazepine-Controlled Release (CBZ-CR))

    Completed
    Has Results
    • Epilepsy
    • Monotherapy
    • Alabaster, Alabama
    • +149 more
    Jun 21, 2018